All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.
Early, encouraging data for glioblastoma treatment reported at ASCO
All of the newly diagnosed glioblastoma multiforme patients enrolled in a Phase 1 clinical trial at the University of Alabama at Birmingham have exceeded both their median and expected progression-free survivals. Two patients, to date, have exceeded their expected overall survival. Glioblastoma multiforme is the most aggressive type of cancer originating in the brain.